Positive amyloid PET
1 paper1 finding
- Humans1
Associations
1APOE
upin humans1
1 study
APOE
upin humans1
APOE is associated with positive amyloid PET in humans (6% (2/2), 5% (2/3), 14% (3/3), 26% (2/4), 29% (3/4), 52% (4/4)).
“6% of 2/2, 5% of 2/3, 14% of 3/3, 26% of 2/4, 29% of 3/4, and 52% of 4/4 participants had a positive amyloid PET”
Humanscognitively unimpairedbrainn = 287
AAIC 2025 abstract24 Dec 2025
Latest
6 in 12 monthsAAIC 2025 Abstract
Relationship between ALZpath pTau217 and cognitive test performance in a primary care sample
Cohort study of 68 peopleBiomarkers
AAIC 2025 Abstract
Plasma p ‐tau217 Performance for Detection of Alzheimer's Disease Neuropathology in Underrepresented Populations
Cohort study in peoplep-Tau217
AAIC 2025 Abstract
Stages of Objective Memory Impairment (SOMI) predicts clinical progression: Findings from the A4 Study
Cohort study of 1,069 peopleMild cognitive impairment
AAIC 2025 Abstract
White matter hyperintensities among Hispanic and non‐Hispanic Whites: the relevance of demographic, biological and non‐biological variables
Cross-sectional study in peoplePopulations
AAIC 2025 Abstract
A resource of data and samples in cognitively unimpaired persons at six levels of Alzheimer's disease risk based on their APOE genotype
Cohort study of 303 peopleAI & data
AAIC 2025 Abstract
Effects of APOE ε4 and sex on estimated ages at amyloid and tau PET positivity
Cohort study of 757 peoplePopulations